Developing effective models of identifying and managing physical health problems amongst mentally ill populations has become a more pressing issue in recent years as the prescription of Second Generation Antipsychotics (SGAs) has burgeoned. Some of the side effects commonly associated with SGAs such as weight gain and metabolic disorders have potentially devastating effects on health and well-being, increasing cardiovascular risk and the incidence of diabetes. The Well-Being Support Programme (WSP), a nurse-led service, was designed to provide a care delivery system whereby physical problems could be identified and appropriate treatment and monitoring initiated by prompt referral to suitable specialist services or general practitioners, forging strong links between primary and secondary care and ensuring that mentally ill patients with physical health problems were receiving holistic care packages. Other problems such as unhealthy lifestyles and obesity were managed by the Nurse Advisor running the programme. Interventions such as weight counselling and groups, and structured exercise programmes were beneficial in terms of encouraging healthier lifestyles, managing obesity and improving self-esteem. This paper describes the manner in which the service was set up and implemented, demonstrating an effective model for identifying and managing physical health problems in the mentally ill.
[1]
J. Thakore.
Metabolic disturbance in first-episode schizophrenia
,
2004,
British Journal of Psychiatry.
[2]
Shubulade Smith,et al.
Sexual dysfunction in patients taking conventional antipsychotic medication
,
2002,
British Journal of Psychiatry.
[3]
J. Thakore,et al.
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
,
2002,
Life sciences.
[4]
H. Nasrallah,et al.
Iatrogenic Disorders Associated with Conventional vs. Atypical Antipsychotics
,
2001,
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[5]
D. Taylor,et al.
Atypical antipsychotics and hyperglycaemia
,
2001,
International clinical psychopharmacology.
[6]
D. Goff,et al.
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
,
2000,
The American journal of psychiatry.
[7]
J. Birtwistle,et al.
The unhealthy lifestyle of people with schizophrenia
,
1999,
Psychological Medicine.